HKEX Stock Code: 01093English|繁體|简体

Highlight - Results for the first nine months of 2025

Revenue
RMB19,891M, -12.3%
Reported profit attributable to shareholders of the Company
RMB3,511M, -7.1%
Underlying profit attributable to shareholders of the Company
RMB3,079M, -23.0%
Basic earnings per share (based on reported profit)
RMB30.72 cents, -4.1%
Basic earnings per share (based on underlying profit)
RMB26.94 cents, -20.5%

Key Products

Finished drugs
Bulk drugs
© Copyright 2025 CSPC Pharmaceutical Group Limited. All Rights Reserved.